PCCT improves the accuracy and consistency of airway biomarker quantification relative to EICT, particularly with optimized protocols. The validated virtual platform enables modality-bias assessment and protocol optimization for accurate, reproducible bronchitis measurements.
Ho et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: